It has come to light that 1,110 Ghanaian women die each year as a result of breast cancer, a debilitating disease that affects the breast of mostly women.


The disease is the second most common cancer among women in Ghana as it forms 40% of all female cancers. Mr Steven Asante, Market Access Manager at Roache Products Ghana Limited- a pharmaceutical company, disclosed this at the launch of an initiative christened Reach For Recovery Ghana in Accra. He said about 2,478 new cases of breast cancer are diagnosed annually in the country.

The disease, he said has sent 1,110 women prematurely to their graves leaving some families in shock and emotional distress, depriving the country of its human resource. He called for a concerted effort to curb the menace.

According to Mr. Asante, it is estimated that about 3,272 women will be diagnosed yearly with cervical cancer, whilst about 1,636 women are destined to die annually based on current prognosis.  He said without intervention the global cancer burden is projected to increase to 75% by 2030.

Mr. Asante avowed that when it comes to cervical cancer, early screening and vaccination provides cure, adding that breast cancer needs to be tackled head-on with all seriousness.  The Market Access Manager of Roache Products Ghana Limited noted that the management of cancer needs a multifaceted approach and multiple partners to tackle it effectively, which is why Roache is leading the way in supporting patient groups in various projects ranging from disease awareness, screening exercises and advocacy issues.

Roche is based in Switzerland. It was founded in 1896 and is one of the world’s largest developer of innovative medicines and diagnostics solutions.

Source: Adovor Nutifafa

 [email protected]


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.